Global Fluorescein Angiography Market – Industry Trends and Forecast to 2029

Fluorescein Angiography Market Analysis and Size

According to the National Eye Institute (NIH), it projects that by 2050, there will be 14.6 million more Americans with diabetic retinopathy than there were in 2010. Therefore, fundus cameras are being employed for diabetic retinopathy early diagnosis. The growth of this market is attributed to the high prevalence of diseases such as cancer and CVD, rising product approvals for advanced angiography techniques in the market, numerous ongoing research activities, growing government and public-private investments, and increasing awareness. 

Data Bridge Market Research analyses that the fluorescein angiography market which was USD 498.8 billion in 2021, would rocket up to USD 658.86 billion by 2029, and is expected to undergo a CAGR of 3.54% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Fluorescein Angiography Market Scope and Segmentation   

Market Definition

Fluorescein angiography quickly injects sodium fluorescein into the forearm vein as a film-forming agent. The fundus camera continually captures the dye circulation outside the fundus blood artery as sodium fluorescein enters the fundus blood vessel with blood flow and passes through a set of colour filters.

Fluorescein Angiography Market Dynamics

Drivers

• Rise in diseases

Fluorescein angiography market growth will likely be boosted throughout the forecast period by factors such as expanding patients with eye problems, increasing government initiatives to utilise fluorescein angiography equipment, and rising demands for early diagnosis.

• Increase in demand of policies

On the other hand, favourable insurance company policies will further promote a number of opportunities that will result in the expansion of the fluorescein angiography market during the period covered by the forecast.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the market growth rate is the rising healthcare expenditure which helps improve its infrastructure. Also, various government organizations aim to improve the healthcare infrastructure by increasing funding, which will further influence the market dynamics.

Opportunities

• Government Initiatives

The market for fluorescein angiography is primarily driven by rising rates of various eye illnesses, rising desire for early detection, and encouraging government initiatives. The World Health Organization (WHO) has launched a global campaign called VISION 2020 to educate people about the effects of blindness as well as governments' long-term political and professional commitment to eradicating the condition. The need for human and financial resources to end blindness must be demonstrated to international decision-makers and NGOs as a wise, profitable investment.

Restraints/Challenges

On the other hand, growing competition among the players regarding technologies will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.

This fluorescein angiography market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the fluorescein angiography market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Fluorescein Angiography Market

Medical supplies are increasingly in demand as a result of the afflicted population. In first-line clinical care, respiratory support devices such atomizers, life support systems, oxygen generators, and monitors are frequently employed. A considerable rise in demand for medical supplies including masks, gloves, and protective eyewear has also been attributed to COVID-19. There is a growing demand for medical supplies from healthcare professionals and the general public due to an increase in COVID-19 cases around the world. Manufacturers of personal protective equipment have the chance to benefit from the increasing demand for medical supplies in order to have a sufficient and continuous supply of these products on the market. Due to such factors, COVID 19 is expected to significantly impact the fluorescein angiography market.

Recent Development

• In August 2019, Maestro2Automated OCT/Fundus Camera was released according to Topcon. The company's ophthalmic portfolio will probably increase as a result of this introduction.

Global Fluorescein Angiography Market Scope

The fluorescein angiography market is segmented on the basis of product, application and technology. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Device
• Disposables
• Accessories

 Technology

• Digital
• Analog

 Application

• Macular Edema
• Macular Degeneration
• Macular Pucker
• Ocular Melanoma
• Diabetic Retinopathy
• Others

Fluorescein Angiography Market Regional Analysis/Insights

The fluorescein angiography market is analysed and market size insights and trends are provided by country, product, application and technology as referenced above.

The countries covered in the fluorescein angiography market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the fluorescein angiography market due to the surging volume of patients suffering from diabetic retinopathy along with prevalence of funds for early diagnosis.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The fluorescein angiography market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for fluorescein angiography market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the fluorescein angiography market. The data is available for historic period 2010-2020.

Competitive Landscape and Fluorescein Angiography Market Share Analysis

The fluorescein angiography market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to fluorescein angiography market.

Some of the major players operating in the fluorescein angiography market are:

• Carl Zeiss Meditec, Inc. (U.S.)
• NIDEK Co., Ltd. (U.S.)
• Kowa Company Ltd. (Japan)
• Topcon Corporation (U.S.)
• Optomed Oy Ltd. (Finland)
• CenterVue SpA (Italy)
• Canon, Inc. (Japan)
• Heidelberg Engineering GmbH (Germany)

SKU-54173